Introduction:
Numerous techniques have been advocated for repair of nasal septal perforations [1] [2] [3] . For symptomatic patients who fail conservative management, the surgical goals can largely be agreed upon to include: 1) Restoration of normal function and physiology to the nose and 2) Reduction of symptoms [4] . However, a consensus on the ideal procedure to achieve complete closure of nasal septal perforations remains elusive. Reconstruction of the nasal septum in three distinct layers using bilateral mucoperichondrial flaps with interpositional grafting has gained widespread acceptance [1, 2, 4, 5] . This method consistently demonstrates closure rates greater than 70% and frequently higher than 90% in numerous series. These rates match favorably with respect to closure by mucoperichondrial advancement omitting the use of interposition grafting [1] . The mechanism for this greater success is theorized to include 1) improved mucosal cellular migration with the graft acting as a scaffold 2) the graft providing a barrier between the bilateral incision lines during healing and 3) the allowance of incomplete mucosal closure on one side of the septum where excessive tension would be required [1, 4] . Even amongst surgeons who employ this method to achieve closure of nasal septal perforations, there is considerable diversity in the choice of interpositional graft material.
Autologous grafts used for the repair of nasal septal perforations include temporalis fascia, septal cartilage and bone, pericranium, mastoid bone and perichondrium, tragal cartilage and perichondrium, ethmoid bone, iliac crest, conchal cartilage, and skin graft [2, 6] . Recently, use of manufactured allografts such as freezedried acellular human dermis, xenografts such porcine small intestinal submucosa (PSIS), and synthetic materials such as bioactive glass has been described [6] [7] [8] [9] Porcine small intestinal submucosa ("SurgiSIS", Cook Biotech Inc, West Lafayette, IN) is a biologic, acellular, freeze-dried, soft tissue graft. It is purified, washed in solutions to eradicate viruses, and sterilized. Small intestinal submucosa mimics the extracellular matrix (ECM) environment. Fibrillar collagens and adhesive glycoproteins serve as a scaffold for cellular migration, and regulatory factors such as glycosaminoglycans, proteoglycans, and growth factors are reportedly retained following processing [10] . Following implantation, SIS encourages angiogenesis, epithelial and connective tissue growth and differentiation, and evolution of recipient site ECM. Porcine SIS has been used in a wide variety of surgical applications including hernia repair, urethral and ureteral reconstruction, pelvic floor reconstruction, and chronic wound dressing.
The senior author (EP) previously reported a case series of 10 patients with nasal septal perforations repaired using an external rhinoplasty approach, bilateral bipedicled mucoperichondrial advancement flaps and interpositional graft consisting of porcine small intestinal submucosa [7] . A rate of closure of 100% was achieved in the early follow-up period. This article updates the series to include 46 patients repaired using this approach, and reviews the series demographics, etiology, outcomes, and risk factors for perforation and complications of repair.
Patients and Methods
Following approval from the Institutional Review Board at Thomas Jefferson University, a retrospective chart review was performed on all patients undergoing nasal septal perforations repair using porcine small intestinal submucosa as an interpositional Page 5 of 16 graft by the senior author (EP), during the time period from 1998-2006. Of a total of 53 patients undergoing septal perforation repair during this same time period, 46 patients underwent 47 repairs using PSIS interpositional graft and the surgical method. The remaining seven patients were closed using silicone sheeting, rib graft, or local advancement flaps alone because of large unstable defects or inadequate mucosa. Two patients in the series had tissue expanders placed, with the expanded mucosa employed at the time of septal perforation repair. One patient underwent revision septal perforation repair with repeated PSIS placement.
Patients with symptomatic nasal septal perforations were considered candidates for repair with PSIS graft. Patients with a history of cocaine abuse were required to abstain for at least 6 months prior to consideration of repair, as well as demonstrate a negative preoperative drug screen. Laboratory workup included screening for granulomatous diseases, rheumatologic diseases and syphilis.
Patients received perioperative antibiotics and corticosteroids. Nasal septal perforation closure was achieved using either an endonasal (n=6) or open rhinoplasty (n=41) approach with bilateral mucoperichondrial advancement flaps covering an interpositional PSIS graft [7] . The PSIS was rehydrated in a gentamicin-normal saline solution for 10 minutes, then shaped and trimmed to the appropriately sized interpositional graft [7] . Septal biopsies were performed intraoperatively. Patients had 0.25 mm silicone splints secured on either side of the repair, which were removed after 3 weeks.
A retrospective chart review abstracted presenting symptoms and an attempt was made to determine the general effect of surgical repair on these symptoms. Two authors (PSM and AAS) subjectively determined the severity of these symptoms both pre and post-operatively as described by office notes and symptom questionnaires. A 4-point scale was created, with "0" representing a lack of symptoms (e.g. for epistaxis, "0" means patient did not experience epistaxis), and scores of 1, 2, and 3 representing mild, moderate, and severe symptoms, respectively.
Results:
Twenty-four percent (11/46) of patients were male. Patient ages ranged from 17-69 years with a mean of 40.4 (stddev=11.4). 63% (29/46) were self-described lifetime nonsmokers, while 19.6% (9/46) were former smokers and 17.4% (8/46) current smokers. The size of perforations ranged from 0.5 cm to 4.7 cm in largest dimension, with a mean approximately 1.7 cm (stddev=0.8 cm). Patients were followed for an average of 18.3 months (stddev=14.2 months), with a range in follow up from 6 months to 4.9 years. See Table 1 for a summary of patient characteristics. Previous surgery, cocaine use, and previous trauma were the most common determined etiologies for these patients (Table 2) . 
Some patients had more than one contributing etiology
The three most frequently reported presenting symptoms were, in descending order: nasal obstruction, crusting, and epistaxis (Table 3) . 
Outcomes

Closure
Forty-seven PSIS repairs were performed on 46 patients. Of the total 47 procedures, 41 (87.2%) continued to be closed at the site of repair during the follow up period. Two procedures were staged, with a planned incompletely closed perforation at the first stage. Excluding these staged procedures, 41/45 (91.1%) continued to be closed at the site of repair during the follow up period.
Failure
Of the total 47 procedures, six perforations (12.8%) remained during the follow up period. Two of the perforations were in the patients scheduled to undergo staged procedures and will be discussed below. The remaining four perforations developed in patients who underwent primary procedures.
Of the total 45 planned complete closures, one patient developed a perforation at the site of closure after the immediate post-operative period (termed "Reperforation"). Three patients developed perforations at sites separate from the site of surgical repair (termed "Second Perforation"). Of note, one of these appeared to be at the site of a splint suture and remains stable at 2mm.
As mentioned above, two failures were in patients scheduled to undergo staged procedures with the expectation of incomplete closure in the immediate post-operative period (termed "Residual Perforation"). Only one of these patients had undergone secondary procedure at the time of writing. The other staged patient had her perforation significantly reduced (1.5 cm to 0.2cm) by the initial procedure, and has not pursued the second stage of operation given the relief of presenting symptoms.
The outcomes of the procedures are listed in Table 4 . As the ultimate goal of this analysis to is to identify risk factors that might allow proper selection of patients and individualized procedures, it is instructive to examine carefully the failures, which include patients who required staged procedures, developed reperforation, or second perforations Table 5 describes the patients in this study who had subtotal closure of their nasal septum. Two procedures were planned staged procedures. Both of these patients had septal perforation repair attempts prior to initial consultation, and 3 cm perforations.
One Three patients (Patients 6, 7, and 8) developed new perforations at a site separate from the original perforation. The second perforations arose at sites near the original perforation and may represent areas of denuded septum during the advancement flap rotation or devascularized tissue from elevation and rotation of the mucoperichondrial flaps. One of these clearly resulted from the splint suture in the anterior septum. 
Symptoms
The results of the preoperative and postoperative profile for the three most commonly reported presenting symptoms are documented in Table 6 . Each of the 3 symptoms is measured on a 4-point scale (0, 1, 2, 3) based on severity of the symptom. A clear shift toward improvement is seen postoperatively. We considered the difference in score (change score = post-op score -pre-op score) as a measure of the change in severity of the symptom. The number of pre-repair symptoms and post-repair symptoms differ, because one patient underwent two procedures. The patient who did not complete the 2 stage procedure is excluded from this table. We found that major symptoms improved after surgery (Table 7) , as expected. Even the patients with subtotal closure of the nasal septal perforation routinely experienced a dramatic improvement of their symptoms, sometimes obviating the indications for further surgical repair. Table 7 displays the frequencies of each possible change score (-3 to +2, with negative values indicating improvement in severity of symptoms) and tests whether, on average, the change score is different from 0. We used the Wilcoxon signed rank test for this, since the data, being a difference of scores, is quite non-normal. We found that all the symptoms showed improvement on average after surgery. 47% showed improvement in epistaxis, 54.55% in obstruction and 55.56% in crusting.
We did note a persistent and paradoxical increase in obstructive symptoms in 5 patients (10.9%) postoperatively. Two of these patients were found to have exuberant granulation and regrowth at the repair site that necessitated surgical intervention. The remainder experienced primarily chronic sinus complaints. Taking into account all patients, including planned staged patients, statistical analysis does correlate repair outcome with perforation size. Table 8 compares, using a two-sample t-test, the mean perforation size between patients with closed perforation post-surgery (~1.5 cm) and patients with the perforation not closed post-surgery (2.6 cm). We find that this average difference of 1.1 cm is statistically significant (p-value=0.011), reinforcing the observation that larger perforations are more likely to have worse outcomes. Other results Biopsy results were available for 35 patients. Two of these (5.7%) supported a diagnosis for granulomatous disease, and the remainder demonstrated various degrees of inflammation without contributing significantly to the diagnostic evaluation. One of the biopsy positive patients was known to have sarcoidosis, and the other had no clinical evidence supporting a systemic disease process. Of two patients known to have sarcoidosis, one (50%) revealed granulomatous disease on biopsy. No nasal septal biopsies led to diagnosis of an unknown systemic process. This is consistent with the findings of Diamantopoulos et al. [11] that demonstrate the low yield of this convention.
